Design, synthesis, pharmacological evaluation and in-silico analysis of quinazoline derivatives as potential therapeutic agents

View at publisher Summarise with VIRAT
Authors: Kholoud Zaki, Zeinab K. Hamza, A. H. Abdel-Rahman, Magdy Mohamed Hemdan, Ibrahim F. Nassar, A. F. Abdel Azim El-Sayed, Mosaad A. Abdel-Wahhab
Cited by: 0
References: 54

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This study focuses on the design, synthesis, and comprehensive biological evaluation of novel quinazoline derivatives as potential therapeutic agents. The structures of nine synthesized compounds were confirmed using spectral methods such as infrared (IR), proton nuclear magnetic resonance (1H NMR) spectroscopy, and elemental analysis. These compounds were assessed for antimicrobial, antioxidant, and anticancer activities against human cancer cell lines including hepatocellular carcinoma (HepG-2), breast cancer (MCF-7), and colorectal carcinoma (HCT-116). Among them, Compounds 8 and 9 exhibited remarkable biological activities. Both compounds demonstrated significant antimicrobial and antioxidant effects, alongside potent antiproliferative activity against (HepG-2), breast cancer (MCF-7) and colorectal carcinoma (HCT-116) cell lines. Notably, Compound 8 showed superior cytotoxicity with IC50 values of 30.81, 53.41, and 76.73 µM against HepG-2, MCF-7, and HCT-116 cells, respectively, outperforming Compound 9. Molecular docking studies corroborated these results, revealing strong binding affinities of Compounds 8 and 9 to key protein targets implicated in antimicrobial and anticancer mechanisms, including Escherichia coli DNA gyrase, Staphylococcus aureus dihydropteroate synthase (DHPS), CDK2 and EGFR. Furthermore, in-silico ADMET predictions indicated favorable drug-likeness and low toxicity risks, aligning with Pfizer’s drug design guidelines. Overall, Compounds 8 and 9 emerge as promising leads with broad-spectrum therapeutic potential for pharmaceutical and food industry applications.

Fields of Study & Subjects

Quinazolinone synthesis and applications Heterocyclic Compound Synthesis and Bioactivity Synthesis and Characterization of Heterocyclic Compounds

Publication details

Journal / source
Phosphorus, sulfur, and silicon and the related elements
Volume
201
Issue
6
Pages
957–979
Publication date
23 March 2026
Language
EN